跳至主要内容
临床试验/ACTRN12613001073796
ACTRN12613001073796已完成1 期

IPX233-B13-01:Evaluation of the Pharmacokinetics of IPX233 Formulations in Healthy Volunteers

Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.0 个研究点目标入组 20 人开始时间: 2013年9月25日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Healthy volunteers between the ages of 18 and 55 years of age (inclusive) at the time of informed consent.

排除标准

  • Any history of drug or alcohol addiction or abuse within the last 5 years.
  • Presence of a clinically significant disorder including acute or chronic infections, or a malignant neoplasm, and/or involving disease in one or more of these organ systems: cardiovascular, respiratory, renal, gastrointestinal, immunologic, hematologic, dermatologic, hepatic, reproductive, endocrine, or neurologic/psychiatric, as determined by clinical investigators.
  • History of or clinical signs of glaucoma, benign prostatic hypertrophy or urinary retention.
  • History of or clinical signs of any form of epilepsy or seizures.

研究者

发起方
Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.

相似试验